Quarterly report pursuant to Section 13 or 15(d)

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.20.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS    
Revenue
Operating Expenses    
General and administrative 1,936,755 1,357,762
Research and development 389,824 922,235
Total Operating Expenses 2,326,579 2,279,997
Other Operating Income and (Loss)    
Other income from joint venture 355,281
Equity in loss from joint venture (1,295,032)
Total Other Operating Income and (Loss) (939,751)
Operating Loss (2,326,579) (3,219,748)
Other Income    
Interest income 62,493 109,221
Total Other Income 62,493 109,221
Net Loss before Income Taxes (2,264,086) (3,110,527)
Income Taxes
Net Loss (2,264,086) (3,110,527)
Accumulated Preferred Stock Dividend (125,911) (120,815)
Deemed additional dividend on preferred stock dividend due to beneficial conversion feature (54,317) (51,371)
Net Loss Attributable to Common Stockholders $ (2,444,314) $ (3,282,713)
Net Loss Per Common Share, Basic and Diluted $ (0.74) $ (1.14)
Weighted Average Number of Common Shares Outstanding 3,294,998 2,885,921